CTMX

CytomX Therapeutics Inc

May 21 • 04:00PM ET

3.76

+0.04 1.08 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: XNCR ZYME STRO JANX NRIX

| Held by: VTI XBI VXF IBB FDM VHT FFSM LABU DFAS IDNA

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.36	Insider Own	22.71%	Shs Outstand	217.69M	Perf Week	-0.53%
Market Cap	818.56M	Forward P/E	-	EPS next Y	-0.52	Insider Trans	-0.38%	Shs Float	168.26M	Perf Month	-18.44%
Enterprise Value	474.71M	PEG	-	EPS next Q	-0.08	Inst Own	81.47%	Short Float	17.68%	Perf Quarter	-30.76%
Income	-62.14M	P/S	23.03	EPS this Y	-183.00%	Inst Trans	6.96%	Short Ratio	4.43	Perf Half Y	2.73%
Sales	35.54M	P/B	2.56	EPS next Y	-22.25%	ROA	-25.83%	Short Interest	29.74M	Perf YTD	-11.74%
Book/sh	1.47	P/C	2.36	EPS next 5Y	-	ROE	-34.29%	52W High	8.21 -54.20%	Perf Year	84.31%
Cash/sh	1.59	P/FCF	-	EPS past 3/5Y	53.93% 27.00%	ROIC	-18.48%	52W Low	1.72 118.60%	Perf 3Y	100.00%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	12.75% -5.36%	Gross Margin	96.51%	Volatility	5.11% 5.43%	Perf 5Y	-55.29%
Dividend TTM	-	EV/Sales	13.36	EPS Y/Y TTM	-173.33%	Oper. Margin	-182.20%	ATR (14)	0.24	Perf 10Y	-62.77%
Dividend Ex-Date	-	Quick Ratio	10.38	Sales Y/Y TTM	-75.91%	Profit Margin	-174.84%	RSI (14)	39.41	Recom	1.10
Dividend Gr. 3/5Y	- -	Current Ratio	10.38	EPS Q/Q	-138.13%	SMA20	-5.01%	Beta	2.13	Target Price	12.30
Payout	-	Debt/Eq	0.01	Sales Q/Q	-79.85%	SMA50	-13.81%	Rel Volume	0.24	Prev Close	3.72
Employees	69	LT Debt/Eq	0.00	Earnings	May 07 AMC	SMA200	-4.67%	Avg Volume	6.71M	Price	3.76
IPO	Oct 08, 2015	Option/Short	Yes / Yes	EPS/Sales Surpr.	17.42% 119.08%	Trades		Volume	1,596,000	Change	1.08%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)